Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.30 |
| ▸ | ADH1C | P00326 | 1/20 | 0.30 |
| ▸ | ADH1A | P07327 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16384539 | 0.77 | — | — | |
| SCHEMBL11601710 | 0.77 | — | — | |
| SCHEMBL18938411 | 0.77 | — | — | |
| SCHEMBL748666 | 0.74 | — | — | |
| SCHEMBL9024649 | 0.74 | — | — | |
| SCHEMBL3215434 | 0.74 | — | — | |
| SCHEMBL18770836 | 0.72 | — | — | |
| SCHEMBL11435371 | 0.72 | — | — | |
| SCHEMBL11245213 | 0.72 | — | — | |
| SCHEMBL10494491 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11865374-B2 | Functionalized polymers | EVONIK OPERATIONS GMBH (DE) | 2024-01-09 | — | — | US | claimed |
| US-20230312791-A1 | FUNCTIONALIZED POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2023-10-05 | — | — | US | claimed |
| EP-4200343-A1 | FUNCTIONALIZED POLYMERS | Evonik Operations GmbH (DE) | 2023-06-28 | — | — | EP | claimed |
| WO-2022038054-A1 | FUNCTIONALIZED POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2022-02-24 | — | — | WO | claimed |
| EP-3957659-A1 | FUNCTIONALIZED POLYMERS | Evonik Operations GmbH (DE) | 2022-02-23 | — | — | EP | claimed |
| EP-3710503-B1 | FUNCTIONALIZED POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2022-01-05 | — | — | EP | claimed |
| US-20200383896-A1 | FUNCTIONALIZED POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2020-12-10 | — | — | US | claimed |
| EP-3710503-A1 | FUNCTIONALIZED POLYMERS | Evonik Degussa GmbH (DE) | 2020-09-23 | — | — | EP | claimed |
| CN-111356710-A | Functionalized polymers | 赢创运营有限公司 | 2020-06-30 | — | — | CN | claimed |
| US-11865374-B2 | Functionalized polymers | EVONIK OPERATIONS GMBH (DE) | 2024-01-09 | — | — | US | disclosed |
| US-20230312791-A1 | FUNCTIONALIZED POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2023-10-05 | — | — | US | disclosed |
| EP-4200343-A1 | FUNCTIONALIZED POLYMERS | Evonik Operations GmbH (DE) | 2023-06-28 | — | — | EP | disclosed |
| CN-111356710-B | Functionalized polymers | 赢创运营有限公司 | 2022-04-26 | — | — | CN | disclosed |
| WO-2022038054-A1 | FUNCTIONALIZED POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2022-02-24 | — | — | WO | disclosed |
| US-20200383896-A1 | FUNCTIONALIZED POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2020-12-10 | — | — | US | disclosed |
| EP-3710503-A1 | FUNCTIONALIZED POLYMERS | Evonik Degussa GmbH (DE) | 2020-09-23 | — | — | EP | disclosed |
| CN-111356710-A | Functionalized polymers | 赢创运营有限公司 | 2020-06-30 | — | — | CN | disclosed |
| US-8268991-B1 | Processes for preparing certain hexaazaisowurtzitanes and their use in preparing hexanitrohexaazaisowurtzitane | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2012-09-18 | — | — | US | disclosed |
| US-4066524-A | IMIDAZOLE POLYMERS AND PREPARATION THEREOF WITH RADIATION AND CHEMICAL INITIATOR | HERCULES INCORPORATED (US) | 1978-01-03 | — | — | US | disclosed |
| US-3948740-A | Polymerization of water soluble monomers with radiation and chemical initiator | HERCULES INCORPORATED (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11865374-B2 | Functionalized polymers | PUF60, PARN, PARG | ADH1B 3723/4885ADH1C 1589/4885ADH1A 1476/4885 |
| US-20200383896-A1 | FUNCTIONALIZED POLYMERS | PUF60, PARN, PARG | ADH1B 3723/4885ADH1C 1589/4885ADH1A 1476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.